Methotrexate vs Spironolactone
Methotrexate vs Spironolactone: Overview
This comparison examines the pharmacological differences between Methotrexate and Spironolactone.
Mechanism of Action
Methotrexate: Dihydrofolate reductase inhibitor.
Spironolactone: Mineralocorticoid receptor antagonist.
Pharmacokinetics
Half-life: Methotrexate — 3-10 hours; Spironolactone — 1.4 hours.
Chemical Properties
Molecular Formula: Methotrexate — C20H22N8O5; Spironolactone — C24H32O4S.
Molecular Weight: Methotrexate — 454.4400 g/mol; Spironolactone — 416.5740 g/mol.
Type: Methotrexate — Small molecule; Spironolactone — Small molecule.